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Abstract
Background: Dietary trans fatty acids (dTFA) are primarily synthetic compounds that have been introduced only recently;
little is known about their behavioral effects. dTFA inhibit production of omega-3 fatty acids, which experimentally have
been shown to reduce aggression. Potential behavioral effects of dTFA merit investigation. We sought to determine
whether dTFA are associated with aggression/irritability.
Methodolgy/Prinicpal Findings: We capitalized on baseline dietary and behavioral assessments in an existing clinical trial
to analyze the relationship of dTFA to aggression. Of 1,018 broadly sampled baseline subjects, the 945 adult men and
women who brought a completed dietary survey to their baseline visit are the target of this analysis. Subjects (seen 1999–
2004) were not on lipid medications, and were without LDL-cholesterol extremes, diabetes, HIV, cancer or heart disease.
Outcomes assessed adverse behaviors with impact on others: Overt Aggression Scale Modified-aggression subscale
(primary behavioral endpoint); Life History of Aggression; Conflict Tactics Scale; and self-rated impatience and irritability.
The association of dTFA to aggression was analyzed via regression and ordinal logit, unadjusted and adjusted for potential
confounders (sex, age, education, alcohol, and smoking). Additional analyses stratified on sex, age, and ethnicity, and
examined the prospective association. Greater dTFA were strongly significantly associated with greater aggression, with
dTFA more consistently predictive than other assessed aggression predictors. The relationship was upheld with
adjustment for confounders, was preserved across sex, age, and ethnicity strata, and held cross-sectionally and
prospectively.
Conclusions/Significance: This study provides the first evidence linking dTFA with behavioral irritability and aggression.
While confounding is always a concern in observational studies, factors including strength and consistency of association,
biological gradient, temporality, and biological plausibility add weight to the prospect of a causal connection. Our results
may have relevance to public policy determinations regarding dietary trans fats.
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Introduction
Dietary trans fatty acids (dTFA) are primarily products of
hydrogenation, a chemical process that makes (unsaturated) oils
solid at room temperature [1]. They are present at high levels in
margarines, shortenings, and prepared foods [2–4]. Adverse health
effects of dTFA have been identified on lipids, metabolic function,
insulin resistance, oxidation, inflammation, and cardiac and
general health [5–20]. Advantageous associations of another class
of fatty acids, long chain omega-3 fatty acids (n3FA), to behavioral
outcomes have been previously reported [21–23].
Due to the range of their deleterious biological effects, including
inhibition by dTFA of n3FA production (by inhibition of delta-6
desaturase activity) [24,25], we theorized that dTFA may be
associated with greater aggression and irritability.
Methods
Subjects
Of 1018 male and female adults, minimum age 20 years,
screened for participation in a clinical trial of lipid-lowering
therapy in a primary prevention setting (the UCSD Statin Study)
[26], 945 had completed a dietary assessment prior to a baseline
visit and were the target of the present assessment. Subjects were
broadly sampled, however persons on lipid medications, or with
very low or high LDL (,115 mg/dL or .190 mg/dL), known
diabetes, cardiovascular disease, HIV, or cancer were excluded
[26].
The study protocol was approved by the University of
California, San Diego Human Research Protections Program.
All subjects gave written informed consent.
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Nutrient data were collected using a food frequency question-
naire developed by the Nutrition Assessment Shared Resource of
the Fred Hutchinson Cancer Research Center [27]. Consumption
frequency and portion size are queried, for a series of food
categories, each in turn defined by a series of foods or beverages.
Additional questions relating to food preparation and purchasing
further refine nutrient calculations (http://www.fhcrc.org/
science/shared_resources/nutrition/ffq/).
Nutrient calculations were performed using the Nutrient Data
System for Research software version 4.03, developed by the
Nutrition Coordinating Center, University of Minnesota Food and
Nutrient Database (version 31, released November 2000), which
added trans fatty acid values in 1998. ‘‘Trans-fatty acid values were
determined for all foods in the database (0% missing) and include
individual contributions of 16:1 trans (trans-hexadecenoic acid);
18:1 trans (trans-octadecenoic acid); and 18:2 trans (trans-octadeca-
dienoic acid), which encompasses cis-trans, trans-cis, and trans-trans
forms; as well as total trans-fatty acids. The USDA table ‘‘Fat and
Fatty Acid Content of Selected Foods Containing Trans-Fatty
Acids’’… was the primary source of trans-fatty acid information for
assignment of values to foods in the database. Additional data
sources included other nutrient databases and articles in the
scientific literature containing trans-fatty acid values for US foods,
using appropriate methodologies’’ [28].
The study period (1999–2004) was advantageous because dTFA
values were available in the nutrient database, while trans fat
composition in foods was relatively stable (USFDA trans fat
labeling requirements were implemented later, Jan 1 2006 [29]).
Behavioral Endpoints
The following validated instruments were used:
N Overt Aggression Scale Modified – Aggression sub-
scale (OASMa) [30–34]. the primary designated aggression
measure, it inquires about actual aggressive behavioral actions
in the prior week.
N Life History of Aggression (LHA) [35]. examines
behavioral aggression over the subject’s lifetime, generally
excluding childhood violence.
N Conflict Tactics Scale (CTS) [36–38]. examines tactics,
including aggressive ones, employed by (or against) the subject
(behavioral hostility or hostile attribution) in the prior 2 weeks.
We employed the portion eliciting behaviors by the subject.
N Impatience. measures self-report of subjective impatience,
asking subjects to rate their impatience on a scale of 0 (not
present) to 10 (maximally present).
N Irritability. measures self-report of subjective irritability,
asking subjects to rate their irritability on a scale of 0 (not
present) to 10 (maximally present).
The latter two instruments have been validated in this study
(construct, convergent, predictive validity; information available
on request).
Covariates
Potential confounders of relevance to aggression assessments
(and related behaviors) included age and sex [39], education,
alcohol [39,40], and smoking [40]. Exercise was examined by two
measures: self-rated activity relative to others your age (5 point
Likert scale from much less active through about the same to much
more active – in models that also adjust for age); and the number
of times in a week exercised vigorously for at least 20 minutes.
Analyses
The association of dTFA to aggression was assessed cross-
sectionally at baseline, prior to any study-related treatment. An
additional prospective analysis capitalized on subsequent assess-
ments of aggression in the placebo group. Regression analyses
were performed for each behavior/aggression outcome, unadjust-
ed and adjusted. The ‘‘full’’ model for each (using heteroskedas-
ticity-independent robust standard errors, aka ‘‘White’’ standard
errors [41]) adjusted for reported aggression predictors (age, sex,
education, alcohol, smoking) and dTFA, allowing for contrast of
consistency of impact of different aggression predictors, including
dTFA. Both least squares regression and ordinal logit were
performed for each outcome, assessing the robustness to regression
approach (including for outcomes where either regression
approach could be justified and, purely for illustration
of robustness, those for which one specification was concep-
tually preferred). Exercise variables were evaluated as potential
confounders.
Additional analyses examined impact of stratification by sex,
ethnicity and age on the relationship between dTFA and OASMa
(the primary aggression endpoint).
Prospective prediction was also assessed, restricted to the
placebo group for simplicity of interpretation (averting concerns
that the intervention could modify the results – though results of
analysis including the total sample are also provided). dTFA at
baseline were examined relative to OASMa at follow-up (6 months
after baseline), adjusting for baseline OASMa.
A prior study looked at trans and saturated fats on depression;
we added this combined analysis (and also examined depression).
Trans fat consumption relates strongly to linoleic acid consump-
tion; we evaluated the effect of each after removing the
contribution by the other; and also examined a model adjusting
simultaneously for the joint trans-saturated variable and the
linoleic variable.
Results
Baseline characteristics are shown in Table 1.
Strongly significant interrelations among the behavioral end-
points (p,0.001) but modest correlation coefficients affirm that the
aggression measures we employed tapped related but distinct
constructs (Table S1 and S2).
Regression analysis showed a strong association between dTFA
and each aggression-related outcome. This association was
retained after adjustment for other predictors, and was more
Table 1. Baseline Subject Characteristics (N=945)*.
Sample Mean (SD) or %
Age (years) 57.2 (12.0)
Male 68.3%
Caucasian 80.1%
Education (scaled 1–9){ 5.82 (1.50)
Current Smoker 7.94%
Alcohol (g/day) 9.64 (14.9)
Trans fat Consumption (g/day) 3.49 (2.47)
*Subjects with trans fat measurement, out of 1,016 subjects appearing for
baseline participation in a clinical trial.
{Education was scored on a 9-point scale, with 1=grade school or less,
9=doctoral degree.
doi:10.1371/journal.pone.0032175.t001
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(Table 2 and Table 3). Coefficients were similar for men and
women (except for irritability) though significance was greater for
men, who were twice as numerous in the sample. Significance was
upheld across age and ethnicity strata. Regression coefficients for
dTFA as a predictor of OASMa by age were: b=0.53 p=0.003
(age 20–40); b=0.27 p=0.003 (age 40–60); b=0.27 p=0.008
(age.60); by ethnicity: b=0.30 p,0.001 (Caucasian); b=0.31
p=0.037 (non-Caucasian).
dTFA significantly predicted future aggression, in adjusted
prospective analysis confined to the placebo group. This was true
even after also adjusting for aggression at time of dTFA assessment
(factoring out the association of baseline aggression with dTFA):
b=0.15 p=0.041. This contrasted with other predictors, for
which the impact on aggression at baseline largely accounted for
the impact at follow-up. (The central follow-up analysis presented
here was in the untreated placebo group. However dTFA also
prospectively preedicted aggression in the statin group: b=0.25,
p=0.032; and in the total sample, adjusted for active treatment, as
well as baseline and on-treatment cholesterol: b=0.21 p=0.009.)
Regarding other potential lifestyle confounders, exercise variables
(62) had no relationship to aggression variables (65) with one
exception: vigorous activity for 20 minutes predicted CTS (one of
10 tested pairings), but the trans fat relationship retained its potent
prediction of aggression with additional adjustment for this
(p=0.001). Linoleic acid (pfa18:2) was collinear with trans fats,
but the residual transfat contribution, after separating out the
shared contribution with pfa18:2 remained strong, 0.23, and
significant, p=0.002. Others have considered trans and saturated
fat variables together for mood associations. A fused trans-
saturated fat variable bore a smaller coefficient consistent with the
lower saturated fat coefficient; significance remained strong
(p=0.001). The pfa18:2 coefficient lost significance (and the
coefficient was negative), when both the trans-saturated variable
and the pfa18:2 variable were included in the model.
Discussion
dTFA showed a significant association to behaviors that have
unfavorable repercussions to others – indeed dTFA were more
consistently predictive than that of other assessed and recognized
aggression predictors. The effect was robust to adjustment for
potential confounders like age, education, smoking, and alcohol.
This is the first study to show a connection of dTFA to aggression.
A role for nutrition and specifically fatty acids in behavior [42]
has been previously reported [43]. Of note, dTFA variably obstruct
production of docosahexaenoic acid, a long chain n3FA that has
protected against aggression-related outcomes in some observation-
al and experimental studies [21–23]. In one animal study the effect
of dTFA on n3FA themselves did not extend to the brain [44].
However, it is unknown whether n3FA behavioral benefits reflect
purely direct effects of n3FA on the brain or indirect effects – e.g.
through effects on prostaglandins and oxidative and inflammatory
mediators that may themselves cross the blood-brain-barrier [45–
47]. Indeed, dTFA mechanisms that could have implications for
aggression include cell energy alterations [18], oxidative stress [15]
and inflammatory effects [10,11]. n3FA have also been linked to
lower depression risk, and analogous reasoning might yield the
hypothesis that trans fats may adversely affect depression. Indeed, a
relation of dTFA and saturated fats to depression has been reported
[48].Theassociationtodepressionwasevidentinoursampleaswell
(based on the Center for Epidemiologic Studies Depression Scale);
but our focus is on the aggression association, which, in our sample,
is considerably stronger. Of note, n3FA intake was not significantly
related to aggression in our sample.
As with all observational studies, there are limitations including
the potential for unmeasured confounding. However, observa-
Table 2. Dietary Trans Fat is Significantly Linked to Aggression Measures.
Aggression Measure
Dietary Trans Fats
Relation to That Measure*
Variable Mean Value ± SD Dietary Trans Fats (grams/day) P-value
b SE
OASMa 2.50±4.72 0.296 0.092 0.001
Conflict Tactics Scale 1.08±1.70 0.101 0.031 0.001
Life History of Aggression 10.1±6.93 0.277 0.106 0.009
Impatience 1.87±2.12 0.0953 0.0372 0.011
Irritability 1.30±1.83 0.084 0.031 0.007
OASMa: Overt Aggression Scale Modified – aggression subscale.
*In regression with robust standard errors, adjusted for age, sex, education, alcohol and smoking.
doi:10.1371/journal.pone.0032175.t002
Table 3. Significance of Dietary Trans Fats Along with Other
Potential Aggression Predictors in Multivariable Adjustment{.
Predictor Aggression Measures
OASMa LHA CTS Impatience Irritability
Age **/** **/** */2 */* **/**
Male 2/2 **/** 2/22 /22 /2
Education */** +/* 2/22 /22 /*
Smoking 2/22 /22 /2 */++ /2
Alcohol 2/2 **/** 2/2 **/* */*
Trans Fats */** **/* **/** */* **/**
OASMa: Overt Aggression Scale Modified – aggression subscale.
LHA: Life History of Aggression. CTS: Conflict Tactics Scale.
2 No significant or borderline association.
+ 0.05,p,0.1 (borderline significant).
*0.01,p,0.05 (significant).
**p,0.01 (highly significant).
{Significance levels shown are results (respectively) of linear regression/ordinal
logit analyses (both with robust standard errors [41]). Analyses for each
aggression outcome are adjusted for each predictor variable.
doi:10.1371/journal.pone.0032175.t003
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intervention studies with randomized dietary trans fat allocation
are unlikely to be pursued due to ethical concerns, given evidence
of other adverse health effects of dTFA.
This study did not employ objective markers of trans fatty acids
such as red blood cell membrane trans fats [49], or plasma
phospholipid trans fats [50], and future studies should seek to
employ these measures to establish whether the relationship is
upheld. Use of these as biomarkers of dTFA [51], may correlate
imperfectly to dTFA. However, while serum markers are
‘‘objective,’’ they also have limitations relative to dTFA. (Other
factors may affect serum level and outcomes, creating an apparent
connection that need not have anything to do with actions of the
nutrient. For illustration, low serum levels of iron may be linked to
colon cancer death, or death from exsanguination, but it is neither
low iron intake nor low iron levels that produce these. Rather, colon
cancer may cause GI bleed and low measured iron at a given iron
intake level, producing the appearance of a connection.) Since one
can intervene upon diet, the association of specifically dTFA to
behavior remains of independent importance.
Trans fat consumption was estimated from dietary recall. Not
all foods that go by the same label have the same trans fat content.
However, provided the misclassification is nondifferential, this
would be expected to produce bias toward the null and could not
explain strong and significant findings. Moreover, this study was
done during a period of relative stability of trans fat content in
foods (1999–2004) prior to more recent efforts to restrict dTFA – a
comparative strength of this investigation.
Trans fat consumption could serve as a marker for other
untoward behaviors and practices that could in turn be linked to
aggression. This concern is somewhat mitigated as our finding
emerged in a clinical trial sample and was preserved with
adjustment for other adverse health behaviors such as smoking
and alcohol. Triangulating evidence and other studies will be
required to more confidently establish whether the association is
causal.
This work also has important strengths. The premise (and
results) are original but rest on a biological foundation. Factors
including the strength of association, consistency, temporality
(prospective prediction), biological gradient (‘‘dose response’’),
biological plausibility, and coherence with other literature – factors
such as those in Hill’s presumptive criteria for causality with
observational data – were evident in our findings, and add weight
to the possibility that the association we identify could have a
causal basis; but confounding cannot be excluded. If the
association is causal, the findings provide one further potential
explanation for the recognized association between hostile/
aggressive behaviors and heart disease. Trans fats could serve as
common cause for both outcomes [20,52–54] (analogous to the
observation that n3FA may serve as a common protection against
both [43]).
If the association is determined to be causal, then the
detrimental effects of trans fats may extend beyond the person
who consumes them to affect others with whom that person
interacts. Should that prove to be the case, the inclusion of
synthetic trans fats in diets may bear reexamination – with
implications to public policy and regulation.
Supporting Information
Table S1 OASMa: Overt Aggression Scale Modified – aggres-
sion subscale. LHA: Life History of Aggression. CTS: Conflict
Tactics Scale. * P,0.0001 for all correlations.
(DOC)
Table S2 OASMa: Overt Aggression Scale Modified - aggres-
sion subscale. LHA: Life History of Aggression. CTS: Conflict
Tactics Scale. Power was greater for men, who represented 68% of
the sample (about twice as many men as women). * Significant
change in aggression shown in bold (P,0.05).
(DOC)
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